Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rudy

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
The Pediatric Infectious Disease Journal|February 23, 2010
Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United StatesColeen K Cunningham, Bret J Rudy, Jiahong Xu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 13, 2017
Partner Notification for Youth Living With HIV in 14 Cities in the United StatesJacob J van den Berg, Marjan Javanbakht, Pamina M Gorbach, et al.
The Journal of Infectious Diseases|February 10, 2004
Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy in adolescents (aged 12-22 years) infected through high-risk behaviorHulin Wu, Janet Lathey, Ping Ruan, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|October 10, 1998
Quantification of penicillin-G and procaine in equine urine and plasma using high-performance liquid chromatographyY Luo, B McNamara, M A Fennell, et al.
JACC. Heart Failure|March 14, 2014
Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b)Barry Greenberg, Alex Yaroshinsky, Krisztina M Zsebo, et al.
Journal of Veterinary Pharmacology and Therapeutics|November 7, 2006
Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horsesD P K Lankveld, B Driessen, L R Soma, et al.
Journal of Leukocyte Biology|January 30, 2018
Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controlsJulie C Williams, Xinrui Zhang, Manju Karki, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpesS L Sacks, S D Shafran, F Diaz-Mitoma, et al.
AIDS Patient Care and Stds|May 16, 2008
Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapyAllison Agwu, Jane C Lindsey, Kimberly Ferguson, et al.
Mbio|March 24, 2025
EV68-228-N monoclonal antibody treatment halts progression of paralysis in a mouse model of EV-D68 induced acute flaccid myelitisMichael J Rudy, Courtney J Wilson, Brendan Hinckley, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
The Pediatric Infectious Disease Journal|February 23, 2010
Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United StatesColeen K Cunningham, Bret J Rudy, Jiahong Xu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 13, 2017
Partner Notification for Youth Living With HIV in 14 Cities in the United StatesJacob J van den Berg, Marjan Javanbakht, Pamina M Gorbach, et al.
The Journal of Infectious Diseases|February 10, 2004
Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy in adolescents (aged 12-22 years) infected through high-risk behaviorHulin Wu, Janet Lathey, Ping Ruan, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|October 10, 1998
Quantification of penicillin-G and procaine in equine urine and plasma using high-performance liquid chromatographyY Luo, B McNamara, M A Fennell, et al.
JACC. Heart Failure|March 14, 2014
Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b)Barry Greenberg, Alex Yaroshinsky, Krisztina M Zsebo, et al.
Journal of Veterinary Pharmacology and Therapeutics|November 7, 2006
Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horsesD P K Lankveld, B Driessen, L R Soma, et al.
Journal of Leukocyte Biology|January 30, 2018
Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controlsJulie C Williams, Xinrui Zhang, Manju Karki, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpesS L Sacks, S D Shafran, F Diaz-Mitoma, et al.
AIDS Patient Care and Stds|May 16, 2008
Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapyAllison Agwu, Jane C Lindsey, Kimberly Ferguson, et al.
Mbio|March 24, 2025
EV68-228-N monoclonal antibody treatment halts progression of paralysis in a mouse model of EV-D68 induced acute flaccid myelitisMichael J Rudy, Courtney J Wilson, Brendan Hinckley, et al.
Pageof 11